about
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocolKnowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol.Safety of licensed vaccines in HIV-infected persons: a systematic review protocol.Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial.The burden of pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunization (EPI) in 1974: a systematic review protocol.Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T CellsHuman newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syrinAdverse events following primary and secondary immunisation with whole-cell pertussis: a systematic review protocol.Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants.Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.H1:IC31 vaccination is safe and induces long-lived TNF-α(+)IL-2(+)CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.Comparison of school based and supplemental vaccination strategies in the delivery of vaccines to 5-19 year olds in Africa - a systematic review.
P50
Q26864948-9B3BFFDD-99A4-4864-B772-E8CA4B6A0370Q30249669-686EFE9B-5281-4057-AE41-ECF1D24201C1Q34167964-DFB6682E-1B8D-4200-BAE5-76174D7A4A00Q34178074-EE205B5D-E3FE-4EF6-8021-A838EA6B2340Q34663035-7041F1BC-E919-48C0-A309-54CDA48AAE95Q35568901-012C27C8-0AE4-4D0B-9E93-938CD8CC3EDAQ35773892-3CFC80BA-DB90-4759-B876-81E4E4B5D7F6Q36018901-360095CD-F163-4AFE-8246-E9A78644B8C8Q36041609-204A6B53-A0B6-4BAF-8888-1E78566BC441Q37612162-551BAB54-EDA5-4D61-96A8-FC84BE7A3C15Q38848196-4DA228BD-3857-4122-96C6-FAE0C52DC11EQ40382721-9ABA63E9-86FC-452C-B62F-E507DA4B79CFQ40443624-A597BA64-4E90-4B02-ACCF-9071D149A736Q48155181-302B7D19-B09E-4966-979D-41AEFF207709
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Benjamin M Kagina
@ast
Benjamin M Kagina
@en
Benjamin M Kagina
@es
Benjamin M Kagina
@nl
type
label
Benjamin M Kagina
@ast
Benjamin M Kagina
@en
Benjamin M Kagina
@es
Benjamin M Kagina
@nl
prefLabel
Benjamin M Kagina
@ast
Benjamin M Kagina
@en
Benjamin M Kagina
@es
Benjamin M Kagina
@nl
P106
P21
P31
P496
0000-0003-4943-9762